AN OVERVIEW ABOUT NOVEL FAST DISSOLVING ORAL FILMS
Nowadays, novel fast dissolving oral films (FDF) have come in existence as an alternative dosage form in comparison with tablet, capsules, syrup and other oral dosage forms with respect to patient convenience and compliance. Fast dissolving oral films are helpful to paediatric and geriatric patients who experience difficulties in swallowing traditional oral solid-dosage forms. The FDF drug delivery systems are solid dosage form which disintegrate or dissolve within seconds when placed in the mouth cavity without need of water or chewing. FDF provide better drug dissolution, faster onset of action, bypassing the first pass metabolism of drugs and thus enhance their oral bioavailability with reduced dosing frequency. These formulations are suitable for cough, cold, sore throat, allergenic conditions, nausea, pain, hypertension and CNS disorders. The present review provides the details about the recent advancement in design and development of oral fast dissolving film.
2. Liang AC and Chen LH. Fast dissolving intraoral drug delivery systems. Expert opinion on therapeutic patents.2001; 11(6):981-86.
3. Borsadia SB, O' Halloran D, Osborne JL. Quick dissolving films- A novel approach to drug delivery, Drug development and delivery.2003; 3(3):63-6.
4. Klancke J. Dissolution testing of orally disintegrating tablets, Dissolution technologies.2003; 10(2):6-8.
5. Parakh SR and Gothoskar AV. A review of mouth dissolving tablet technologies. Pharm tech.2003; 27(11):92-100.
6. Siddiqui MDN, Garg G, Sharma PK. A short review on “A novel approach in oral fast dissolving drug delivery system and their patents”. Advances in biological research.2011; 5(6):291-303.
7. Galey WR, Lonsdale HK, Nacht S. The in-vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. Journal of investigative dermatology.1976; 67(6):713-17.
8. Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: Innovations in formulation and technology. International journal of pharmaceutical sciences review and research.2011; 9(2):50-7.
9. Dixit RP, Puthli SP. Oral strip technology: Overview and future potential. Journal of controlled release. 2009; 139(2):94–107.
10. Bradoo R, Shahani S, Poojary S, Deewan B. Fast dissolving drug delivery systems. JAMA.2001; 4(10):27-31.
11. Bhowmik D, Krishnakanth CB, Chandira MR. Fast dissolving tablet: An overview. Journal of chemical and pharmaceutical research. 2009; 1(1):163-77.
12. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: An innovative drug delivery system and dosage form. International journal of chemtech research.2010; 2(1):576-83.
13. Kundu S, Sahoo PK. Recent trends in the development of orally disintegrating tablet technology pharmaceutics. Pharma times. 2008; 40(4):4-11.
14. Kunte S and Tandale P. Fast dissolving strips: A novel approach for the delivery of verapamil. Journal of pharmacy and bioallied science. 2010; 2(4):325-28.
15. Francesco C, Cupone IE, Minghetti P, Buratti S, Selmin F, Montanari L. Nicotine fast dissolving films made of maltodextrins: A feasibility study. AAPS PharmSciTech.2010; 11(4):1511-17.
16. Choudhary DR, Patel VA, Kundawala AJ. Formulation and evaluation of quick dissolving film of levocetirizine dihydrochloride. International journal of pharmatech.2011; 3(1):1740-49.
17. Saini S, Nanda A, Dhari J. Formulation, development & evaluation of oral fast dissolving antiallergic film of levocetrizine dihydrochloride. Journal of pharmaceutical science & research.2011; 3(7):1322-25.
18. Sakellariou P and Rowe RC. Interactions in cellulose derivative films for oral drug delivery. Journal of polymer science. 1995; 20:889-942.
19. Pharmaceutical manufacturing encyclopedia.3rd edition. William andrew publishing: East- west press Pvt. Ltd.; 2006. p.2512.
20. Singh P, Guillory JK, Sokoloski TD, Benet L.Z, Bhatia VN. Effect of inert tablet ingredients on drug absorption I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. Journal of pharmaceutical sciences. 1966; 55(1):63-8.
21. Raju S, Reddy PS, Kumar VA, Deepthi A, Reddy KS, Reddy PVM. Flash release oral films of metoclopramide hydrochloride for pediatric use: formulation and in-vitro evaluation. Journal of chemical and pharmaceutical research.2011; 3(4):636-46.
22. Banker GS. Film coating theory and practice. Journal of pharmaceutical sciences.1966; 55: 81-9.
23. Cilurzo F, Cupone IE, Minghetti P, Buratti S, Gennari C, Montanari L. Diclofenac fast- dissolving film: suppression of bitterness by a taste-sensing system. Drug development and industrial pharmacy.2011; 7(3):252-59.
24. Prasanthi NL, Krishna CS, Gupta ME, Rao NR. Design and development of sublingual fast dissolving films for an antiasthmatic drug. Der pharmacialetter.2011; 3(1):382-95.
25. Leung SHS, Leone RS, Robert, Kumar LD, Sorg AF. Fast dissolving orally consumable films. U.S. Patent. 2003; 22(6).
26. Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T. Preparation of fast dissolving oral thin film containing dexamethasone: A possible application to antiemesis during cancer chemotherapy. European journal of pharmaceutics and biopharmaceutics.2009; 73:361-65.
27. Cilruzo F and Cupone EI. Fast dissolving films made of maltodextrins. European Journal of Pharmaceutics and Biopharmaceutics.2008; 70:895-900.
28. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolving tablet of nimusulide using vacuum drying technique. AAPS PharmSciTech.2004; 5:45-9.
29. Patel R, Shardul N, Patel J, Baria A. Formulation development and evaluation of mouth melting film of ondansetron. Archives of pharmaceutical science & research. 2009; 1:212-17.
30. Patel VF, Liu F, Brown M. Advances in oral transmucosal drug delivery. Journal of controlled release. 2011; 153:106-16.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Rights of Authors:
The International Journal of Drug Regulatory affairs. recognize the retention of the following:
- Patent and trademark rights and rights to any process or procedure described in the article.
- The right to photocopy or make single electronic copies of the article for their own personal use, including for their own classroom use, or for the personal use of colleagues, provided the copies are not offered for sale and are not distributed in a systematic way outside of their employing institution (e.g. via an e-mail list or public file server). Posting of an article on a secure network (not accessible to the public) within the author’s institution is permitted.
- The right, subsequent to publication, to use the article or any part thereof free of charge in a printed compilation of works of their own, such as collected writings or lecture notes.
Note: All copies, paper, electronic or other use, of the information must include an indication of the IJDRA copyright and a full citation of the journal source.
- If the article was prepared jointly with other author(s), the signing author has informed the co-author(s) of the terms of this copyright transfer and is signing on their behalf as their agent and represents that he or she is authorized to do so, then please confirm by checking the appropriate box following the signature line. The signing author shall bear the responsibility for designating the co-author(s) and must inform the IJDRA of any changes in authorship.
- If copyright is held by the employer, then the employer or an authorized representative of the employer must sign. If the author signs, it is understood that this is with the authorization of the employer and the employer’s acceptance of the terms of the transfer.
The author(s) warrant(s) that the article is the author’s original work and has not been published before. The author(s) warrant(s) that the article contains no libelous or other unlawful statements, and does not infringe on the rights of others. If excerpts from copyrighted works are included, the author(s) has (have) obtained or will obtain written permission from the copyright owners and will credit the source in the article.
Preprints: The author(s) must agree that if a prior version of this work (normally a preprint) has been posted to an electronic public server, they will not update and/or replace the prior version in order to make it identical in content to the final published version.